Skip to main content
Baijin Life Science Holdings Limited logo

Baijin Life Science Holdings Limited — Investor Relations & Filings

Ticker · 1466 ISIN · KYG0130B1014 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 577 across all filing types
Latest filing 2026-06-01 Regulatory Filings
Country HK Hong Kong
Listing HKEX 1466

About Baijin Life Science Holdings Limited

https://www.baijinlifescience.com

Baijin Life Science Holdings Limited is an investment holding company operating through two primary segments: Life Science and Fine Jewellery. The Life Science division is positioned as a biopharmaceutical entity dedicated to anti-aging, preventive medicine, and cellular precision therapy. Core activities in this segment include the research and development of cellular drugs and large molecule drugs, provision of clinical research services, and the R&D and sales of a self-owned skincare brand. Concurrently, the Fine Jewellery segment engages in the design, production (ODM/OEM basis), processing, trading, and wholesale distribution of precious stones and jewelry products.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2026
Regulatory Filings Classification · 88% confidence The document is a monthly regulatory return filed to the Hong Kong Exchange detailing movements in share capital, issued shares, treasury shares, public float confirmation, and share option movements under Chapter 19B Listing Rules. It is a standard compliance submission rather than a financial report (e.g., annual or interim report), management presentation, or announcement of a specific corporate action. This falls under general regulatory announcements/fallback category: Regulatory Filings (RNS).
2026-06-01 English
VOLUNTARY ANNOUNCEMENT STRATEGIC COOPERATION FRAMEWORK AGREEMENT
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by Baijin Life Science Holdings Limited regarding a strategic cooperation framework agreement with another company. It discusses the nature of the cooperation, regulatory context, and potential future agreements. There are no financial statements, no detailed financial data, no earnings information, no voting results, no management or board changes, and no regulatory certifications. The document is an announcement of a business development event, specifically a strategic cooperation agreement, which fits best under a general regulatory announcement category. It is not a report, transcript, or detailed financial disclosure. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length is 5266 characters, which is sufficient to contain substantive content but it is clearly an announcement rather than a report or detailed filing.
2026-05-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026
Regulatory Filings Classification · 95% confidence The document is a monthly return filing to the Hong Kong Exchanges and Clearing Limited (HKEX) regarding movements in securities for Baijin Life Science Holdings Limited. It details movements in authorized share capital, issued shares, share options, and confirms compliance with listing rules and regulatory requirements. The document is structured as a regulatory submission form (FF301) and does not contain financial statements, earnings data, or management discussion. It is not an annual or interim report, earnings release, or investor presentation. It is a regulatory filing reporting share capital and share movement information as required by the exchange rules. The document length is about 9,610 characters, which is substantive but focused on share capital movements and confirmations. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2026-05-05 English
GRANT OF SHARE OPTIONS UNDER THE 2024 SHARE OPTION SCHEME
Share Issue/Capital Change Classification · 80% confidence The document is an official announcement under the Hong Kong Listing Rules disclosing the grant of share options under the company’s share option scheme. It details the number of share options granted to directors and employees, the exercise price, vesting period, and compliance with Listing Rules. This is not an annual report, earnings release, management discussion, or minutes of an AGM, nor is it a simple report publication announcement. Instead, it pertains to a capital change event—the issuance of share options which may lead to future share issuance. Therefore, it falls under the “Share Issue/Capital Change” category (Code: SHA).
2026-04-24 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2026
Regulatory Filings Classification · 90% confidence The document is a monthly regulatory return submitted to the Hong Kong Exchange detailing movements in authorised share capital, issued shares, treasury shares, and public float confirmations under Chapter 19B of the Listing Rules. It is not an investor presentation, financial report (10-K/IR), audit report, board change notice, or dividend declaration, nor does it announce a specific capital transaction (no changes recorded). It is a standard compliance filing under exchange listing rules, fitting the catch-all Regulatory Filings category.
2026-04-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2026
Regulatory Filings Classification · 95% confidence The document is a 'Monthly Return for Equity Issuer' (Form FF301) filed with the Hong Kong Stock Exchange (HKEX). This form is a standard regulatory requirement for listed companies in Hong Kong to report monthly movements in securities, share capital, and public float status. Since it is a recurring regulatory filing regarding share capital and listing compliance that does not fit into specific categories like 'Share Issue' (which is for specific events) or 'Transaction in Own Shares' (which is for buybacks), it is best classified as a general regulatory filing.
2026-03-04 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.